ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

LH vs JNJ // FREE CASH FLOW YIELD

Labcorp Holdings Inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: LH 5 — JNJ 9
▲ FREE CASH FLOW YIELD LEADER: LH
fcf-yield
4.04%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LH VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC LH JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 28.80% 67.90% -39.10 JNJ /gross-margins <GO>
Return on Invested Capital (ROIC) 8.30% 25.50% -17.20 JNJ /roic <GO>
EV/EBITDA & P/E Valuation 19.6x 18.5x +1.10 JNJ /valuation <GO>
Free Cash Flow Yield ACTIVE 4.04% 2.97% +1.07 LH /fcf-yield <GO>
Operating Margin 9.90% 34.70% -24.80 JNJ /operating-margins <GO>
Net Profit Margin 6.30% 28.50% -22.20 JNJ /net-margins <GO>
Revenue Growth (YoY) 7.20% 6.00% +1.20 LH /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.81% 0.00% +0.81 LH /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.58 5.59 -2.01 JNJ /balance-sheet <GO>
Piotroski F-Score Quality 8/9 8/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew 6.80% 7.20% -0.40 LH /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 74.5 60.4 +14.19 LH /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.96 1.08 -0.12 JNJ /macro-sensitivity <GO>
Forward P/E Multiple 31.6x 23.0x +8.60 JNJ /forward-pe <GO>
Enterprise Scale & Market Cap $29.86B $662.49B -$632.63B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR LH REV JNJ REV LH GROSS % JNJ GROSS % LH FCF JNJ FCF
FY 2025 $13.95B $94.19B 28.8% 67.9% $1.21B $19.70B
FY 2024 $13.01B $88.82B 27.9% 69.1% $1.10B $19.84B
FY 2023 $12.16B $85.16B 44.0% 44.0% $780.4M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LH // BETA 0.96
JNJ // BETA 1.08